# FDA Inspection 1219663 - Zealand Pharma A/S - June 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/zealand-pharma-as/1c3d0366-5070-4239-ae24-fcc725399765
Source feed: FDA_Inspections

> FDA Inspection 1219663 for Zealand Pharma A/S on June 14, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219663
- Company Name: Zealand Pharma A/S
- Inspection Date: 2023-06-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1248947 - 2024-09-06](https://www.keypedia.com/records/fda_inspections/zealand-pharma-as/b3ceaaa9-3d77-4e74-927f-49ccede785d7)
- [FDA Inspection 1248947 - 2024-09-06](https://www.keypedia.com/records/fda_inspections/zealand-pharma-as/3aa9fc89-08fc-44fc-ac05-22aa8f8eadd8)

Company: https://www.keypedia.com/companies/zealand-pharma-as/07254bf6-6c9f-4fc5-b9d5-4c3128fa98a3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c